Strategic Partners, Inc. v. Vestagen Protective Tech. Inc.
This text of Strategic Partners, Inc. v. Vestagen Protective Tech. Inc. (Strategic Partners, Inc. v. Vestagen Protective Tech. Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Ninth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
FILED NOT FOR PUBLICATION SEP 16 2019 UNITED STATES COURT OF APPEALS MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS
FOR THE NINTH CIRCUIT
STRATEGIC PARTNERS, INC., Nos. 17-56789 18-55156 Plaintiff-counter- defendant-Appellee, D.C. No. 2:16-cv-05900-RGK-PLA v.
VESTAGEN PROTECTIVE MEMORANDUM* TECHNOLOGIES, INC.,
Defendant-counter-claimant- Appellant.
STRATEGIC PARTNERS, INC., No. 17-56897
Plaintiff-counter- D.C. No. defendant-Appellant, 2:16-cv-05900-RGK-PLA
v.
VESTAGEN PROTECTIVE TECHNOLOGIES, INC.,
Defendant-counter-claimant- Appellee.
* This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. Appeal from the United States District Court for the Central District of California R. Gary Klausner, District Judge, Presiding
Argued and Submitted September 10, 2019 Pasadena, California
Before: RAWLINSON, IKUTA, and BADE, Circuit Judges.
Vestagen Protective Technologies, Inc. appeals the district court’s dismissal
of its counterclaims against Strategic Partners, Inc. (SPI) and its award of
attorneys’ fees to SPI. SPI cross-appeals the district court’s denial of its post-
verdict motions for judgment as a matter of law (JMOL) and, in the alternative, a
new trial. We have jurisdiction under 28 U.S.C. § 1291.
The district court did not abuse its discretion in dismissing Vestagen’s
counterclaims without leave to amend. Vestagen’s unfair business practices
counterclaim, Cal. Bus. & Prof. Code § 17200 (UCL), and unjust enrichment
counterclaim are superseded by the California Uniform Trade Secrets Act
(CUTSA), see K.C. Multimedia, Inc. v. Bank of Am. Tech. & Operations, Inc., 171
Cal. App. 4th 939, 958 (2009), and Vestagen’s proposed amendments to its
complaint are either superseded by CUTSA or fail to state a claim. Therefore, the
district court did not err in denying Vestagen leave to amend. Dougherty v. City of
Covina, 654 F.3d 892, 901 (9th Cir. 2011).
2 The district court did not err in dismissing Vestagen’s false advertising
counterclaim as a matter of law. The district court did not abuse its discretion by
excluding expert testimony regarding SPI’s advertising, because the expert was not
qualified to testify about the scientific aspects of SPI’s advertisement, see United
States v. Chang, 207 F.3d 1169, 1172–73 (9th Cir. 2000), and his non-scientific
testimony did not satisfy the reliability threshold, see Kumho Tire Co., Ltd. v.
Carmichael, 526 U.S. 137, 152 (1999). Although the district court’s relative
inflexibility in setting time limits is not favored and came close to the line, we
ultimately conclude the court did not abuse its discretion by denying Vestagen’s
request for additional time. See Gen. Signal Corp. v. MCI Telecomms. Corp., 66
F.3d 1500, 1507–09 (9th Cir. 1995).
In light of the evidence at trial, the district court did not err in concluding
that the nondisclosure agreement (NDA) signed by Vestagen on November 27,
2011, was the only binding agreement between the parties. See Integrated Health
Servs. of Green Briar, Inc. v. Lopez-Silvero, 827 So. 2d 338, 339 (Fla. Dist. Ct.
App. 2002). The court did not err in dismissing Vestagen’s breach of contract
counterclaim as a matter of law, because SPI’s alleged disruption of the American
Society of Testing Materials (ASTM) meeting did not violate any provision of the
NDA.
3 Finally, the court did not err in dismissing Vestagen’s misappropriation of
trade secrets counterclaim as a matter of law, because Vestagen disclosed its
business strategy through its public efforts to have ASTM adopt higher standards
favorable to Vestagen. See Abba Rubber Co. v. Seaquist, 235 Cal. App. 3d 1, 18
(1991). Because Vestagen’s business strategy did not constitute a trade secret,
evidence related to Vestagen’s participation in ASTM was not relevant to proving
misappropriation of trade secrets, see United States v. Alvarez, 358 F.3d 1194,
1205 (9th Cir. 2004), and the district court did not abuse its discretion in excluding
such evidence on relevance grounds.
The district court correctly determined that SPI was the prevailing party on
the breach of contract counterclaim, and therefore was entitled to attorneys’ fees
under the NDA. See Rose v. Rose, 615 So. 2d 203, 204 (Fla. Dist. Ct. App. 1993).
The district court did not err in denying SPI’s post-verdict motions for
JMOL and, in the alternative, a new trial. Even assuming that Vestagen’s
advertisements contained statements that are literally false, see Southland Sod
Farms v. Stover Seed Co., 108 F.3d 1134, 1139 (9th Cir. 1997), a reasonable jury
could conclude that Vestagen’s advertisements neither deceived the public nor
influenced customers’ purchasing decisions. See Reeves v. Sanderson Plumbing
Prods., Inc., 530 U.S. 133, 149 (2000). For the same reason, the district court did
4 not abuse its discretion in denying the motion for a new trial. See Molski v. M.J.
Cable, Inc., 481 F.3d 724, 729 (9th Cir. 2007).
AFFIRMED.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Strategic Partners, Inc. v. Vestagen Protective Tech. Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/strategic-partners-inc-v-vestagen-protective-tech-inc-ca9-2019.